Brian Rubenstein

Brian Rubenstein: Attorney with Greenberg Traurig, LLP
  • Shareholder at Greenberg Traurig, LLP (2024 Attorneys)
  • 2700 Two Commerce Square, 2700 Two Commerce Square, 2001 Market Street, Philadelphia, PA 19103
    View Brian Rubenstein's office location
  • Peer Reviews

    No Reviews
  • Profile Visibility [ i ]


Brian Rubenstein has a broad range of experience defending pharmaceutical and other companies in a range of large-scale, complex matters. Prior to joining Greenberg Traurig, Brian was with Teva Pharmaceuticals, USA, Inc. from 2005 to 2018, where he most recently served as Senior Director, Associate General Counsel. At Teva, he managed and exercised direct oversight of Teva’s portfolio of product liability, patent settlement antitrust, and other commercial matters, managing a multimillion-dollar annual legal budget.

Brian guided and counseled Teva through all stages of litigation and dispute resolution, both in federal court and in numerous state court jurisdictions. Most prominently, he managed Teva’s involvement in the landmark U.S. Supreme Court case, Pliva v. Mensing , in which the majority found that “failure to warn” product liability lawsuits against generic pharmaceutical manufacturers are preempted by federal law, a sea change in the law concerning generic pre-emption. He also counseled Teva on antitrust issues, in particular “pay to delay” matters, as well as on labeling and related regulatory issues. In addition, he provided counseling to various business units to ensure compliance with the existing regulatory regime, as well as created and implemented strategies to adapt to potential rule changes for generic pharmaceutical products.

Brian has experience investigating and coordinating responses to government subpoenas as well as FDA and FTC inquiries. Prior to joining Teva, he litigated business disputes, including advertising and intellectual property disputes, at a large New York law firm.


•Products liability
•FDA compliance and inquiry responses
•FTC compliance and inquiry responses
•Multidistrict and mass tort litigation


•Hon. William J. Bauer, U.S. Court of Appeals for the Seventh Circuit, 1998-1999

Areas of Practice (3)

  • Litigation
  • Pharmaceutical, Medical Device & Health Care Litigation
  • Products Liability & Mass Torts

Education & Credentials

Contact Information:
215.988.7864  Phone
University Attended:
Wharton School of Business, University of Pennsylvania, B.S., 1995
Law School Attended:
Loyola University Chicago School of Law, J.D., cum laude, 1998; Member, Loyola University Chicago Law Journal
Year of First Admission:
Pennsylvania; New York
Birth Information:
Philadelphia, Pennsylvania, April 8, 1973
Reported Cases:
Experience: Representative Matters: Oversaw management and litigation strategy of numerous pharmaceutical product liability mass torts in both state and federal court.; Led litigation strategy and management of the first patent settlement antitrust case to go to trial post- FTC vs. Actavis, Inc ., the 2013 ruling where the U.S. Supreme Court set the standard for determining whether patent settlement agreements between NDA holders and ANDA holders violate the antitrust laws.; Managed numerous multidistrict class action antitrust litigations.; The above representations were handled by Mr. Rubenstein prior to joining Greenberg Traurig, LLP.; In-House Experience: Teva Pharmaceuticals, USA, Inc.; Senior Director, Associate General Counsel, 2012-2018; Senior Counsel, 2010-2012; Counsel, 2008-2010; Associate Counsel, 2005-2008

Peer Reviews

This lawyer does not have peer reviews.

*Peer Reviews provided before April 15, 2008 are not displayed.

Philadelphia, Pennsylvania

Contact Brian Rubenstein

Required Fields

Required Fields

By clicking on the "Submit" button, you agree to the Terms of Use, Supplemental Terms and Privacy Policy. You also consent to be contacted at the phone number you provided, including by autodials, text messages and/or pre-recorded calls, from Martindale and its affiliates and from or on behalf of attorneys you request or contact through this site. Consent is not a condition of purchase.

You should not send any sensitive or confidential information through this site. Emails sent through this site do not create an attorney-client relationship and may not be treated as privileged or confidential. The lawyer or law firm you are contacting is not required to, and may choose not to, accept you as a client. The Internet is not necessarily secure and emails sent though this site could be intercepted or read by third parties.